B C M de Winter
Overview
Explore the profile of B C M de Winter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
78
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hassanzai M, Bahmany S, van Onzenoort H, van Oldenrijk J, Koch B, de Winter B
J Antimicrob Chemother
. 2025 Feb;
PMID: 39969104
Background: A drawback of vancomycin use is the need for therapeutic drug monitoring and renal function monitoring. Traditional blood sampling involves drawing blood through a venepuncture. An alternative method, dried...
2.
Bruens K, Srivastava A, Ringeling L, Hermans R, Liang J, Koch B, et al.
Tijdschr Psychiatr
. 2025 Jan;
66(10):586-590.
PMID: 39749593
Background: The SPACe 2: STAR trial is a multicenter trial in children with an autism spectrum disorder, divided over nine centers in the Netherlands. However, it is challenging to include...
3.
Hermans R, Gangapersad R, Kloosterboer S, van Schaik R, Hillegers M, Koch B, et al.
Eur Neuropsychopharmacol
. 2024 Apr;
85:5-7.
PMID: 38643629
No abstract available.
4.
Smeets T, van der Sijs H, Janssens H, Ruijgrok E, de Winter B
J Cyst Fibros
. 2024 Jan;
23(3):563-565.
PMID: 38281825
Lumacaftor/ivacaftor (Orkambi®, LUM/IVA) is indicated for the treatment of cystic fibrosis (CF) patients aged ≥ 2 years with homozygous F580del mutation in the CFTR gene. Triazole fungal agents are used...
5.
Francke M, Visser W, Severs D, de Mik-van Egmond A, Hesselink D, de Winter B
Eur J Clin Pharmacol
. 2022 May;
78(8):1273-1287.
PMID: 35567629
Purpose: A population pharmacokinetic (popPK) model may be used to improve tacrolimus dosing and minimize under- and overexposure in kidney transplant recipients. It is unknown how body composition parameters relate...
6.
Bais Y, Hermans R, Schuiling-Veninga C, Bos H, Kloosterboer S, de Winter B, et al.
Eur Child Adolesc Psychiatry
. 2022 Feb;
32(8):1427-1434.
PMID: 35138475
Objective: The Dutch law on youth care (the Youth Act) was implemented from 2015 onwards. One of the government's aims by implementing this new policy was de-medicalization of youths by...
7.
van der Heijden L, Mian P, Hias J, de Winter B, Tournoy J, Van der Linden L, et al.
Drugs Aging
. 2021 Dec;
39(1):83-95.
PMID: 34918212
Introduction: Paracetamol pharmacokinetics (PK) is highly variable in older fit adults after intravenous administration. Frailty and oral administration likely result in additional variability. The aim was to determine oral paracetamol...
8.
Sebek L, de Winter B, Bethlehem C, Prins G, Huisman R, Alsma J
Neth J Med
. 2020 Dec;
78(6):404-407.
PMID: 33380548
Approximately 500 patients per year are admitted to the emergency department (ED) of the Erasmus University Medical Center presenting with intoxications with medication. For adequate treatment, it is sometimes important...
9.
Andrews L, Hesselink D, van Schaik R, van Gelder T, de Fijter J, Lloberas N, et al.
Br J Clin Pharmacol
. 2018 Dec;
85(3):601-615.
PMID: 30552703
Aims: The aims of this study were to describe the pharmacokinetics of tacrolimus immediately after kidney transplantation, and to develop a clinical tool for selecting the best starting dose for...
10.
Mian P, van Esdonk M, Olkkola K, de Winter B, Liukas A, Spriet I, et al.
Br J Clin Pharmacol
. 2018 Oct;
85(1):126-135.
PMID: 30321459
Aims: Paracetamol is the analgesic most used by older people. The physiological changes occurring with ageing influence the pharmacokinetics (PK) of paracetamol and its variability. We performed a population PK-analysis...